Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
Completed · Not applicable
Conditions studied: Brain Tumor, Central Nervous System Tumor
In brief
RATIONALE: Drugs used in chemotherapy, such as carboplatin, vincristine, and temozolomide, work in different ways to stop tumor cells from dividing so they stop growing or die. Giving more than one drug may kill more tumor cells. PURPOSE: This pilot study is studying giving carboplatin and vincristine together with temozolomide in treating children with progressive and/or symptomatic low-grade glioma.
Key facts
- Study ID
- NCT00077207
- Run by
- Children's Oncology Group
- People needed
- 66
- Starts
- 2004-07-01
- Expected to finish
- 2013-12-01
- Last updated by the study team
- 2018-05-16
Who can join
Age: any, up to 10. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Childrens Oncology Group — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.